What is the quality of the evidence regarding the relative effect of mineralocorticoid receptor antagonist on renal function (change in creatinine (umol / L) - continuous) in treating heart failure?
The quality of the evidence regarding the relative effect of mineralocorticoid receptor antagonist on renal function (change in creatinine (umol / L) - continuous) in treating heart failure is moderate due to risk of bias. The mean renal function (change in creatinine (umol / l) - continuous) in the control groups was The mean renal function (change in creatinine (umol / l) - continuous) in the intervention groups was